Rejuvenating premature aging

Nat Med. 2008 Jul;14(7):713-5. doi: 10.1038/nm0708-713.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Animals
  • Bone Density Conservation Agents / pharmacology*
  • Cell Nucleus / drug effects
  • Diphosphonates / pharmacology*
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Farnesyltranstransferase / antagonists & inhibitors
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Imidazoles / pharmacology*
  • Lamin Type A
  • Longevity / drug effects
  • Mice
  • Mice, Knockout
  • Nuclear Proteins / metabolism
  • Pravastatin / pharmacology*
  • Prenylation / drug effects
  • Progeria / drug therapy*
  • Progeria / genetics
  • Protein Precursors / metabolism
  • Tumor Suppressor Protein p53 / metabolism
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Imidazoles
  • Lamin Type A
  • Nuclear Proteins
  • Protein Precursors
  • Tumor Suppressor Protein p53
  • prelamin A
  • Zoledronic Acid
  • Farnesyltranstransferase
  • Pravastatin